22nd Century Revenue 2011-2024 | XXII
22nd Century revenue from 2011 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
22nd Century Annual Revenue
(Millions of US $) |
| 2023 |
$32 |
| 2022 |
$41 |
| 2021 |
$31 |
| 2020 |
$28 |
| 2019 |
$26 |
| 2018 |
$26 |
| 2017 |
$17 |
| 2016 |
$12 |
| 2015 |
$9 |
| 2014 |
$1 |
| 2013 |
$7 |
| 2012 |
$0 |
| 2011 |
$1 |
| 2010 |
$0 |
22nd Century Quarterly Revenue
(Millions of US $) |
| 2024-09-30 |
$6 |
| 2024-06-30 |
$8 |
| 2024-03-31 |
$6 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$8 |
| 2023-03-31 |
$9 |
| 2022-12-31 |
$-2 |
| 2022-09-30 |
$19 |
| 2022-06-30 |
$14 |
| 2022-03-31 |
$9 |
| 2021-12-31 |
$8 |
| 2021-09-30 |
$8 |
| 2021-06-30 |
$8 |
| 2021-03-31 |
$7 |
| 2020-12-31 |
$7 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$6 |
| 2020-03-31 |
$7 |
| 2019-12-31 |
$7 |
| 2019-09-30 |
$6 |
| 2019-06-30 |
$6 |
| 2019-03-31 |
$6 |
| 2018-12-31 |
$7 |
| 2018-09-30 |
$6 |
| 2018-06-30 |
$7 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
$6 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$4 |
| 2017-03-31 |
$2 |
| 2016-12-31 |
$3 |
| 2016-09-30 |
$3 |
| 2016-06-30 |
$3 |
| 2016-03-31 |
$3 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$1 |
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$0 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$-0 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.005B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
